Skip to Main Content

Drama, thy name is Amarin.

If you want to get a rise out of investors who have been following Amarin, the maker of the fish-oil-derived heart drug Vascepa, try mentioning the name of Cleveland Clinic cardiologist Dr. Steven Nissen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.